A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)
about
A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)
@en
type
label
A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)
@en
prefLabel
A Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)
@en
P1476
An Open-Label, Dose Escalation ...... Advanced or Metastatic Cancers
@en
P3098
NCT00635778
P580
2006-08-07T00:00:00Z
P582
2008-11-05T00:00:00Z